Kenneth Edwin Schmader, MD

Professor of Medicine
Director of the GRECC and ACOS for Geriatrics and Extended Care
Senior Fellow in the Center for the Study of Aging and Human Development
Campus mail Duke Box 3469, Durham, NC 27710
Phone (919) 660-7572
Email address schma001@mc.duke.edu

Dr. Schmader's primary area of research is herpes zoster and postherpetic neuralgia (PHN) and vaccines in older adults. He conducts pre-clinical, epidemiological and intervention studies of zoster and PHN, particularly with the zoster and influenza vaccines. He is involved with other adult vaccine development in older adults. With colleagues in the Division of Infectious Diseases, Dr. Schmader investigates other infections in older adults.

Another major research focus is adverse drug reactions, medication prescribing and pharmacoepidemiology in the elderly. The objective of the medication work is to reduce adverse drug reactions, improve inappropriate prescribing and determine drug use patterns in the elderly.

Education and Training

  • Fellow in Geriatrics, Medicine, Duke University, 1986 - 1988
  • Chief Medical Resident, Medicine, University of Wisconsin at Madison, 1983 - 1983
  • Medical Resident, Medicine, University of Wisconsin at Madison, 1980 - 1983
  • M.D., Wake Forest University, 1980

Publications

Whitson, HE, Duan-Porter, W, Schmader, K, Morey, M, Cohen, HJ, and Colón-Emeric, C. "Response to Ukraintseva et al. Letter: Resilience Versus Robustness in Aging." The Journals of Gerontology Series A: Biological Sciences and Medical Sciences 71, no. 11 (November 2016): 1535-1536. (Letter)

PMID
27445404
Full Text

Walco, GA, Krane, EJ, Schmader, KE, and Weiner, DK. "Applying a Lifespan Developmental Perspective to Chronic Pain: Pediatrics to Geriatrics." The journal of pain : official journal of the American Pain Society 17, no. 9 Suppl (September 2016): T108-T117. (Review)

PMID
27586828
Full Text

Kurupati, R, Kossenkov, A, Haut, L, Kannan, S, Xiang, Z, Li, Y, Doyle, S, Liu, Q, Schmader, K, Showe, L, and Ertl, H. "Race-related differences in antibody responses to the inactivated influenza vaccine are linked to distinct pre-vaccination gene expression profiles in blood." Oncotarget 7, no. 39 (September 2016): 62898-62911.

PMID
27588486
Full Text

Polsunas, PJ, Sowa, G, Fritz, JM, Gentili, A, Morone, NE, Raja, SN, Rodriguez, E, Schmader, K, Scholten, JD, and Weiner, DK. "Deconstructing Chronic Low Back Pain in the Older Adult-Step by Step Evidence and Expert-Based Recommendations for Evaluation and Treatment: Part X: Sacroiliac Joint Syndrome." Pain medicine (Malden, Mass.) 17, no. 9 (September 2016): 1638-1647.

PMID
27605679
Full Text

Schmader, K. "Herpes Zoster." Clinics in geriatric medicine 32, no. 3 (August 2016): 539-553. (Review)

PMID
27394022
Full Text

Whitson, HE, Duan-Porter, W, Schmader, KE, Morey, MC, Cohen, HJ, and Colón-Emeric, CS. "Physical Resilience in Older Adults: Systematic Review and Development of an Emerging Construct." The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences 71, no. 4 (April 2016): 489-495. (Review)

PMID
26718984
Full Text

Heath, B, Bernhardt, J, Michalski, TJ, Crnich, CJ, Moehring, R, Schmader, KE, Olds, D, Higgins, PA, and Jump, RLP. "Results of a Veterans Affairs employee education program on antimicrobial stewardship for older adults." American Journal of Infection Control 44, no. 3 (March 2016): 349-351.

PMID
26553404
Full Text

Naples, JG, Hanlon, JT, Schmader, KE, and Semla, TP. "Recent Literature on Medication Errors and Adverse Drug Events in Older Adults." Journal of the American Geriatrics Society 64, no. 2 (February 2016): 401-408. (Review)

PMID
26804210
Full Text

Van Epps, P, Schmader, KE, and Canaday, DH. "Herpes Zoster Vaccination: Controversies and Common Clinical Questions." Gerontology 62, no. 2 (January 2016): 150-154.

PMID
26184711
Full Text

Levin, MJ, Schmader, KE, Pang, L, Williams-Diaz, A, Zerbe, G, Canniff, J, Johnson, MJ, Caldas, Y, Cho, A, Lang, N, Su, S-C, Parrino, J, Popmihajlov, Z, and Weinberg, A. "Cellular and Humoral Responses to a Second Dose of Herpes Zoster Vaccine Administered 10 Years After the First Dose Among Older Adults." The Journal of Infectious Diseases 213, no. 1 (January 2016): 14-22.

PMID
26452397
Full Text

Pages